Company News for November 15, 2022
- Microsoft Corporation’s MSFT shares fell 2.3% due to the broader tech crisis.
- Moderna, Inc.’s RNAM shares rose 4.6% as its Omicron vaccines showed a better immune response than the original vaccine.
- Shares of Bath & Body Works, Inc. BBWI plunged 8.2% on fears of poor retail sector performance amid macro headwinds, even as the company is set to report quarterly results Wednesday.
- Shares of Tyson Foods, Inc. TSN fell 3.8% after reporting earnings of $1.63 per share in the fourth quarter of fiscal 2022, missing Zacks’ consensus estimate of $1.70 per share.
Zacks names ‘only one best choice for doubling up’
From thousands of stocks, 5 Zacks experts have each picked their favorite to skyrocket by +100% or more in the coming months. Of these 5, Research Director Sheraz Mian selects one to have the most explosive advantage of all.
It’s a little-known chemical company that’s up 65% year-on-year, but still very cheap. With relentless demand, rising earnings estimates for 2022 and $1.5 billion for stock buybacks, retail investors could step in at any time.
This company could rival or surpass other recent Zacks stocks that are expected to double, such as Boston Beer Company which jumped +143.0% in just over 9 months and NVIDIA which jumped +175.9% in one. year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.